Jonathan Wolleben Analyst Performance

Managing Director at Citizens Jmp

Jonathan Wolleben is a stock analyst at Citizens Jmp focused in the healthcare sector, covering 30 publicly traded companies. Over the past year, Jonathan Wolleben has issued 61 stock ratings, including buy, hold, and sell recommendations. While full access to Jonathan Wolleben's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jonathan Wolleben's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
149 Last 6 Years
Buy Recommendations
93.01% 133 Buy Ratings
Companies Covered
30 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.4%2 ratings
Buy91.6%131 ratings
Hold6.3%9 ratings
Sell0.7%1 ratings

Out of 143 total stock ratings issued by Jonathan Wolleben at Citizens Jmp, the majority (91.6%) have been Buy recommendations, followed by 6.3% Hold, 1.4% Strong Buy, and 0.7% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
30 companies

Jonathan Wolleben, an analyst at Citizens Jmp, currently covers 30 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
29 companies
96.7%
Miscellaneous
1 company
3.3%

Jonathan Wolleben of Citizens Jmp specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
24 companies
80.0%
PHARMACEUTICALS
5 companies
16.7%
Miscellaneous
1 company
3.3%

Jonathan Wolleben's Ratings History at Citizens Jmp

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Quince Therapeutics, Inc. stock logo
IRLA
Quince Therapeutics
11/16/2026Boost Price Target$39.80$86.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
11/12/2026Set Price Target$43.31$143.00
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
11/4/2026Boost Price Target$86.44$166.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
11/4/2026Boost Price Target$87.03$167.00Market Outperform
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
10/29/2026Lower Price Target$10.35$47.00Market Outperform
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
10/16/2026Reiterated Rating$4.05$17.00Market Outperform
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
10/14/2026Reiterated Rating$1.26$7.00Market Outperform
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
10/1/2026Lower Price Target$9.88$27.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
9/24/2026Reiterated Rating$49.42$144.00Market Outperform
Quince Therapeutics, Inc. stock logo
QNCX
Quince Therapeutics
9/22/2026Upgrade$31.00$77.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
9/9/2026Boost Price Target$37.84$79.00Market Outperform
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
9/9/2026Reiterated Rating$40.38$110.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/27/2026Reiterated Rating$97.55$137.00Market Outperform
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
8/14/2026Boost Price Target$9.28$29.00Market Outperform
Annexon, Inc. stock logo
ANNX
Annexon
8/13/2026Upgrade$5.33Market Perform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
8/13/2026Lower Price Target$48.38$144.00Market Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
8/13/2026Boost Price Target$35.58$75.00Market Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
8/10/2026Downgrade$4.09Market Perform
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
8/7/2026Lower Price Target$52.16$110.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/6/2026Lower Price Target$105.79$137.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
8/5/2026Boost Price Target$108.43$160.00Market Outperform
Annexon, Inc. stock logo
ANNX
Annexon
7/21/2026Initiated Coverage$5.57$3.00Market Underperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
7/7/2026Downgrade$83.49Hold
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
6/30/2026Boost Price Target$16.07$55.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
6/15/2026Boost Price Target$102.33$146.00Market Outperform
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
6/15/2026Reiterated Rating$4.07$11.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
6/11/2026Reiterated Rating$32.99$95.00Market Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
5/26/2026Reiterated Rating$41.13$63.00Market Outperform
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
5/19/2026Lower Price Target$6.66$12.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
5/14/2026Lower Price Target$57.14$150.00Market Outperform
Altimmune, Inc. stock logo
ALT
Altimmune
5/14/2026Lower Price Target$2.97$11.00Market Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
5/13/2026Lower Price Target$32.08$74.00Market Outperform
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
5/13/2026Lower Price Target$4.63$25.00Market Outperform
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
5/13/2026Lower Price Target$5.05$11.00Market Outperform
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
5/12/2026Boost Price Target$40.08$86.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
5/8/2026Lower Price Target$38.03$95.00Market Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/7/2026Boost Price Target$8.65$28.00Market Outperform
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
5/6/2026Boost Price Target$101.13$137.00Market Outperform
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
5/5/2026Initiated Coverage$1.48$9.00Market Outperform
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
5/1/2026Boost Price Target$19.93$55.00Market Outperform
Worse than socialism (Ad)

Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel

Watch Porter Stansberry's full investment broadcast now
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
4/29/2026Downgrade$26.66Hold
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
4/28/2026Initiated Coverage$5.12$12.00Market Perform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
4/28/2026Boost Price Target$38.62$97.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
4/21/2026Reiterated Rating$94.25$132.00Market Outperform
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
3/27/2026Boost Price Target$20.75$47.00Market Outperform
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
3/26/2026Lower Price Target$16.83$28.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
3/17/2026Lower Price Target$90.07$152.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
3/10/2026Lower Price Target$62.11$170.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
3/2/2026Lower Price Target$41.10$96.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
2/27/2026Boost Price Target$98.07$176.00Market Outperform
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
2/27/2026Lower Price Target$64.75$113.00Market Outperform
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
2/26/2026Boost Price Target$86.85$112.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
2/26/2026Lower Price Target$92.21$132.00Market Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
2/24/2026Initiated Coverage$36.10$63.00Market Outperform
Quince Therapeutics, Inc. stock logo
QNCX
Quince Therapeutics
1/30/2026Downgrade$0.27Market Perform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
1/20/2026Boost Price Target$501.68$745.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
1/8/2026Lower Price Target$53.34$105.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
12/19/2025Boost Price Target$70.28$140.00Market Outperform
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/17/2025Boost Price Target$17.98$45.00Market Outperform
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
12/12/2025Boost Price Target$67.44$120.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
12/12/2025Boost Price Target$117.62$167.00Market Outperform
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
11/14/2025Boost Price Target$7.61$35.00Market Outperform
Savara Inc. stock logo
SVRA
Savara
11/13/2025Lower Price Target$4.12$10.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
11/11/2025Set Price Target$115.61$259.00
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
11/11/2025Boost Price Target$115.61$259.00Market Outperform
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
11/11/2025Lower Price Target$10.89$28.00Market Outperform
Altimmune, Inc. stock logo
ALT
Altimmune
11/7/2025Lower Price Target$3.94$14.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
11/7/2025Lower Price Target$43.49$108.00Market Outperform
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
11/7/2025Boost Price Target$79.63$102.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
11/5/2025Set Price Target$70.97$95.00
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
11/5/2025Set Price Target$444.64$527.00
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
11/5/2025Lower Price Target$6.76$25.00Market Outperform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
11/5/2025Boost Price Target$444.64$527.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
11/5/2025Boost Price Target$70.97$95.00Market Outperform
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
11/3/2025Initiated Coverage$5.03$20.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
10/28/2025Set Price Target$123.02$254.00Market Outperform
Savara Inc. stock logo
SVRA
Savara
10/23/2025Boost Price Target$4.11$11.00Market Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
10/15/2025Boost Price Target$6.42$27.00Market Outperform
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
10/15/2025Reiterated Rating$11.61Market Perform
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
10/1/2025Boost Price Target$11.69$29.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
9/26/2025Boost Price Target$35.89$143.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
9/25/2025Boost Price Target$96.86$142.00Market Outperform
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
9/12/2025Boost Price Target$14.81$28.00Market Outperform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
8/20/2025Boost Price Target$379.55$485.00Market Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
8/15/2025Lower Price Target$4.30$18.00Market Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
8/13/2025Lower Price Target$21.47$52.00Market Outperform
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
8/13/2025Boost Price Target$6.88$26.00Market Outperform
Quince Therapeutics, Inc. stock logo
QNCX
Quince Therapeutics
8/12/2025Lower Price Target$314.00$1,600.00Market Outperform
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
8/11/2025Lower Price Target$26.85$86.00Market Outperform
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
8/7/2025Lower Price Target$16.31$87.00Market Outperform
The Democrats can’t stop this (Ad)

Porter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypassing Congress under a national emergency. His new briefing outlines three steps to prepare and names a core group of assets tied to the initiative that he says could surge. He points to the 1970s Nixon-era reset, which reportedly minted an average of 1,300 new millionaires a day for over half a century.tc pixel

Get Porter Stansberry's briefing on Trump's new dollar and the three steps he outlines.
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
8/7/2025Boost Price Target$53.42$69.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/7/2025Set Price Target$59.41$81.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
8/6/2025Boost Price Target$89.85$135.00Market Outperform
Altimmune, Inc. stock logo
ALT
Altimmune
7/10/2025Lower Price Target$4.21$15.00Market Outperform
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
7/8/2025Boost Price Target$15.69$27.00Market Outperform
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
6/27/2025Reiterated Rating$2.16$8.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
6/26/2025Reiterated Rating$62.19$84.00Market Outperform
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
6/26/2025Reiterated Rating$9.06$21.00Market Outperform
Skye Bioscience, Inc. stock logo
SKYE
Skye Bioscience
6/24/2025Reiterated Rating$25.27$120.00Market Outperform
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
6/23/2025Reiterated Rating$21.73$89.00Market Outperform
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
5/27/2025Boost Price Target$8.41$21.00Market Outperform
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
5/23/2025Reiterated Rating$5.91$19.00Market Outperform
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
5/16/2025Reiterated Rating$13.23$75.00Market Outperform
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/9/2025Boost Price Target$45.07$76.00Market Outperform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
4/24/2025Reiterated Rating$308.00$443.00Market Outperform
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
4/10/2025Initiated Coverage$6.12$38.00Market Outperform
Rallybio Corporation stock logo
RLYB
Rallybio
4/8/2025Downgrade$0.25Hold
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
3/26/2025Set Price Target$5.25$19.00
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
2/7/2025Reiterated Rating$39.61$58.00Market Outperform
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
1/31/2025Initiated Coverage$7.49$26.00Outperform
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
1/31/2025Initiated Coverage$8.77$19.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
1/31/2025Boost Price Target$18.06$55.00Market Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
1/31/2025Reiterated Rating$7.96$18.00Market Outperform
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
1/31/2025Upgrade$7.86Strong-Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
1/31/2025Upgrade$8.91Strong-Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
1/10/2025Reiterated Rating$4.14$10.00Market Outperform
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
1/10/2025Reiterated Rating$330.62$427.00Market Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
12/23/2024Reiterated Rating$56.12$75.00Market Outperform
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
12/11/2024Downgrade$0.43Hold